Baxter is a multinational, pharmaceutical and biomedical company operating in more than 100 countries, with over 50,000 employees. In operation for more than 80 years worldwide, and over 40 years in Italy, the company has been helping healthcare professionals and patients by providing them therapies for the treatment of serious and chronic conditions. In 2013, the acquisition of the Swedish company Gambro AB was completed on a global level. On 1 July 2015, Baxter split its business areas, giving life to two global independent companies operating in the field of health. The 'new' Baxter provides a broad portfolio of products, with both hospital and home-based medical and renal therapies.